Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

Axogen, Inc.

AXGN Clue Score44
United States Fiscal year ends December CIK 0000805928 Results filed 28 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Amy McBride Wendell
12 May 2023
Director
Exercised, kept
3,750
$9.22
$34.58K
Amy McBride Wendell
12 May 2023
Director
Exercised, kept
25,000
$9.22
$230.50K
Erick Wayne DeVinney
27 Dec 2022
VP Peripheral Nerve Science
Exercised, kept
20,000
$5.09
$101.80K
Karen L. Zaderej
15 Dec 2022
CEO
Exercised, kept
26,746
$5.09
$136.14K
Peter J Mariani
14 Dec 2022
EVP & Chief Financial Officer
Exercised, kept
19,364
$5.04
$97.59K
Gregory Gene Freitag
25 Jul 2022
Director
Exercised, kept
83,000
$3.38
$280.54K
Michael Patrick Donovan
22 Feb 2022
VP Operations
Exercised, kept
5,000
$5.45
$27.25K
Michael Patrick Donovan
22 Feb 2022
VP Operations
Exercised, kept
10,000
$5.09
$50.90K
Erick Wayne DeVinney
15 Dec 2021
VP Peripheral Nerve Science
Exercised, kept
10,000
$3.67
$36.70K
Karen L. Zaderej
24 Nov 2021
CEO
Exercised, kept
52,375
$8.95
$468.76K
Karen L. Zaderej
13 Aug 2021
CEO
Exercised, kept
46,500
$3.67
$170.66K
Karen L. Zaderej
12 Aug 2021
CEO
Exercised, kept
8,254
$5.09
$42.01K
Karen L. Zaderej
10 Aug 2021
CEO
Exercised, kept
75,000
$5.09
$381.75K
Gregory Gene Freitag
17 Jun 2021
Director
Exercised, kept
9,250
$19.17
$177.32K
Gregory Gene Freitag
4 Jun 2021
Director
Exercised, kept
24,000
$3.67
$88.08K
Gregory Gene Freitag
26 May 2021
Director
Exercised, kept
50,000
$8.95
$447.50K
Gregory Gene Freitag
26 May 2021
Director
Exercised, kept
15,000
$5.45
$81.75K
Gregory Gene Freitag
26 May 2021
Director
Exercised, kept
6,000
$5.45
$32.70K
Gregory Gene Freitag
26 May 2021
Director
Exercised, kept
9,000
$5.09
$45.81K
Gregory Gene Freitag
26 May 2021
Director
Exercised, kept
22,954
$3.67
$84.24K
Guido J Neels
19 May 2021
Director
Exercised, kept
15,000
$5.09
$76.35K
Guido J Neels
19 May 2021
Director
Exercised, kept
25,000
$3.80
$95.00K
Erick Wayne DeVinney
28 Apr 2021
VP of Clin. & Trans. Sciences
Exercised, kept
10,000
$2.86
$28.60K
Karen L. Zaderej
16 Apr 2021
CEO
Exercised, kept
100,000
$5.09
$509.00K
Karen L. Zaderej
25 Mar 2021
CEO
Exercised, kept
34,500
$3.67
$126.62K
Michael Patrick Donovan
5 Feb 2021
VP Operations
Exercised, kept
20,000
$5.14
$102.80K
Karen L. Zaderej
23 Dec 2020
CEO
Exercised, kept
19,375
$4.81
$93.19K
Erick Wayne DeVinney
15 Dec 2020
VP, Clinical&Translational Sc
Exercised, kept
15,000
$4.81
$72.15K
Mark Louis Friedman
3 Dec 2020
VP,Regulatory & Quality
Exercised, kept
3,187
$3.67
$11.70K
Mark Louis Friedman
3 Dec 2020
VP,Regulatory & Quality
Exercised, kept
625
$4.81
$3.01K
Gregory Gene Freitag
15 Sep 2020
Director
Exercised, kept
13,046
$3.67
$47.88K
Gregory Gene Freitag
29 May 2020
General Counsel
Exercised, kept
125,000
$3.50
$437.50K
Michael Patrick Donovan
28 May 2020
VP Operations
Exercised, kept
5,000
$5.14
$25.70K
Michael Patrick Donovan
28 May 2020
VP Operations
Exercised, kept
10,000
$3.67
$36.70K
Erick Wayne DeVinney
28 Apr 2020
VP, Clinical&Translational Sc
Exercised, kept
2,530
$0.27
$683.10
Karen L. Zaderej
16 Apr 2020
CEO
Exercised, kept
11,625
$4.81
$55.92K
Robert James Rudelius
1 Jan 2020
Director
Exercised, kept
13,000
$2.75
$35.75K
Michael Patrick Donovan
8 Oct 2019
VP Operations
Exercised, kept
1,500
$2.90
$4.35K
Michael Patrick Donovan
8 Oct 2019
VP Operations
Exercised, kept
5,000
$4.81
$24.05K
Karen L. Zaderej
29 May 2019
CEO
Exercised, kept
18,056
$0.27
$4.88K
Karen L. Zaderej
19 Nov 2018
CEO
Exercised, kept
70,000
$2.74
$191.80K
Karen L. Zaderej
19 Nov 2018
CEO
Exercised, kept
30,000
$2.74
$82.20K
Erick Wayne DeVinney
13 Nov 2018
VP, Clinical&Translational Sc
Exercised, kept
274
$0.27
$73.98
Erick Wayne DeVinney
13 Nov 2018
VP, Clinical&Translational Sc
Exercised, kept
35,000
$2.74
$95.90K
Jamie Mark Grooms
20 Sep 2018
Director
Exercised, kept
12,000
$2.75
$33.00K
Jamie Mark Grooms
20 Sep 2018
Director
Exercised, kept
494
$0.27
$133.38
Shawn F McCarrey
7 Aug 2018
SVP Sales
Exercised, kept
55,000
$3.67
$201.85K
Karen L. Zaderej
2 Aug 2018
CEO
Exercised, kept
175,000
$2.74
$479.50K
Robert James Rudelius
8 Jun 2018
Director
Exercised, kept
12,000
$2.75
$33.00K
Mark Stephen Gold
1 Jun 2018
Director
Exercised, kept
15,000
$14.85
$222.75K
Michael Patrick Donovan
26 Mar 2018
VP Operations
Exercised, kept
30,000
$2.74
$82.20K
David K Hansen
22 Mar 2018
VP Finance & Treasurer
Exercised, kept
1,500
$2.75
$4.13K
David K Hansen
22 Mar 2018
VP Finance & Treasurer
Exercised, kept
35,000
$2.74
$95.90K
Gregory Gene Freitag
21 Mar 2018
General Counsel & SVP BD
Exercised, kept
15,000
$4.81
$72.15K
Gregory Gene Freitag
21 Mar 2018
General Counsel & SVP BD
Exercised, kept
16,000
$2.46
$39.36K
Gregory Gene Freitag
1 Mar 2018
General Counsel & SVP BD
Exercised, kept
36,000
$2.74
$98.64K
Mark Stephen Gold
13 Nov 2017
Director
Exercised, kept
15,000
$5.09
$76.35K
Jamie Mark Grooms
1 Nov 2017
Director
Exercised, kept
14,379
$0.27
$3.88K
Mark Louis Friedman
24 Oct 2017
VP,Regulatory & Quality
Exercised, kept
16,829
$1.07
$18.01K
Mark Louis Friedman
24 Oct 2017
VP,Regulatory & Quality
Exercised, kept
4,375
$4.81
$21.04K
Mark Louis Friedman
24 Oct 2017
VP,Regulatory & Quality
Exercised, kept
5,313
$3.67
$19.50K
Mark Louis Friedman
24 Oct 2017
VP,Regulatory & Quality
Exercised, kept
1,250
$5.45
$6.81K
Mark Louis Friedman
24 Oct 2017
VP,Regulatory & Quality
Exercised, kept
40,000
$2.74
$109.60K
Gregory Gene Freitag
25 Sep 2017
General Counsel & SVP BD
Exercised, kept
10,000
$2.74
$27.40K
Robert James Rudelius
8 Sep 2017
Director
Exercised, kept
20,000
$3.50
$70.00K
Gregory Gene Freitag
27 Aug 2017
General Counsel & SVP BD
Exercised, kept
23,000
$2.74
$63.02K
Mark Stephen Gold
30 May 2017
Director
Exercised, kept
5,000
$8.95
$44.75K
Mark Stephen Gold
22 May 2017
Director
Exercised, kept
15,000
$4.81
$72.15K
Michael Patrick Donovan
14 Mar 2017
VP Operations
Exercised, kept
5,000
$2.74
$13.70K
Michael Patrick Donovan
14 Mar 2017
VP Operations
Exercised, kept
4,659
$0.27
$1.26K
Erick Wayne DeVinney
14 Mar 2017
VP, Clinical&Translational Sc
Exercised, kept
359
$0.27
$96.93
Erick Wayne DeVinney
14 Mar 2017
VP, Clinical&Translational Sc
Exercised, kept
4,659
$0.27
$1.26K
Gregory Gene Freitag
30 Dec 2016
General Counsel & SVP BD
Exercised, kept
23,000
$2.74
$63.02K

What was left out

Form 4 filings counted 472
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 48
Sales at will 93
Transactions with no price 0
Shares from compensation/vesting 5,060,938
Sales filed before the plan box existed 57
History held since 24 Sep 2007